Locations:
Cleveland Clinic hematologist highlights new guidelines and treatment advances in immune thrombocytopenia
Making decisions that prioritize biological age and functional status over chronological age alone
Leveraging technology while preserving the human touch
Change eliminates waste associated with dual-field approach
NIMBLE replaces weekly tumor board delays with same-day multidisciplinary recommendations
The selective D1/D5 dopamine agonist provides symptom relief and improves daily function.
Cleveland Clinic study provides validation for the test, which combines AI and pathological data to predict outcomes in postoperative patients
Advanced imaging technology catches metastases much earlier, allowing treatment with fewer side effects
Integrating behavioral health expertise into the management of complex neurological disorders
How careful measurement, provocative testing and repeat assessment can maximize the diagnostic value of PAC
Reduced radiation for lymph node areas reduces side effects
Translating clinical questions into meaningful, sustainable change
For severe cases, complete unroofing of the bridge is imperative
Large Cleveland Clinic analysis may help resolve a longstanding question over optimal fractionation
What the discovery means for clinicians and patients
Device may offer a practical middle-ground option for some patients
Search